Conversion upon Maturity Date. On the Maturity Date without any action on the part of the Holder, the outstanding principal and accrued and unpaid interest under the Notes will be converted into shares of Common Stock at a conversion price equal to the closing price of the Common Stock on the Maturity Date.
Appears in 4 contracts
Sources: Convertible Promissory Note (Bionik Laboratories Corp.), Secured Convertible Promissory Note (Bionik Laboratories Corp.), Secured Convertible Promissory Note (Bionik Laboratories Corp.)
Conversion upon Maturity Date. On the Maturity Date without any action on the part of the Holder, the outstanding principal and accrued and unpaid interest under the Notes will be converted into shares of Common Stock at a conversion price equal to of US$9.50 per share (the closing price of the Common Stock on the Maturity Date“Conversion Price”).
Appears in 1 contract
Sources: Secured Convertible Promissory Note (Bionik Laboratories Corp.)
Conversion upon Maturity Date. On the Maturity Date without any action on the part of the Holder, the outstanding principal and accrued and unpaid interest under the Notes will be converted into shares of Common Stock at a conversion price equal to of US$6.80 per share (the closing price of the Common Stock on the Maturity Date“Conversion Price”).
Appears in 1 contract
Sources: Secured Convertible Promissory Note (Bionik Laboratories Corp.)
Conversion upon Maturity Date. On the Maturity Date without any action on the part of the Holder, the outstanding principal and accrued and unpaid interest under the Notes will be converted into shares of Common Stock at a conversion price equal to the closing price of the Common Stock on the Maturity Date$0.60 per share.
Appears in 1 contract
Sources: Convertible Promissory Note (Bionik Laboratories Corp.)